Demystifying the ROI of Clinical AI
Demystifying the ROI of Clinical AI
Related Articles
New US sweat sensors track health in real-time with printed ink
Caltech just manufactured a wearable sweat sensor that “inkjet prints” biomarkers to better monitor the human body.
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
Nature Biotechnology – An AI-generated small-molecule inhibitor treats fibrosis in vivo and in phase I clinical trials.
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
Nature Biotechnology – An AI-generated small-molecule inhibitor treats fibrosis in vivo and in phase I clinical trials.
HHMI kills program aimed at boosting inclusivity in STEM education
“Inclusive excellence” program had committed $60 million to 104 institutions
EU issues guidelines on banned AI practices
The EU guidelines highlight prohibitions on harmful manipulation, real-time biometric identification and social scoring.
The fight against cholera is far from over. This Bangladeshi scientist is at the front lines
Firdausi Qadri hopes widespread use of cheap oral cholera vaccines can help vanquish an old scourge
Best in KLAS 2025 sees industry progress and vendor momentum
Despite staffing shortages and chaotic work environments, market researchers said increased clinician EHR satisfaction, improved payer/provider relationships and progress on SDOH are advancing
La Pine Community Health Center lays off 11% of staff while awaiting further word on federal funding freeze
La Pine Community Health Center has laid off 11% of its staff of 90, pending more details about a freeze on federal funding, but said…
Whale song shows language-like statistical structure
Humpback whale song is a culturally transmitted behavior. Human language, which is also culturally transmitted, has statistically coherent parts whose frequency distribution follows a power…
Andreessen Horowitz, Eli Lilly partner on biotech ecosystem fund
The alliance will focus on developing new medicines, allowing novel modality platforms and scaling emerging health technologies.